Tanabe K - Search Results

1

[Combination chemotherapy of S-1 and docetaxel on advanced and recurrent gastric cancer].

Yoshida K, Wada Y, Tanabe K, Ukon K, Hihara J. Yoshida K, et al. Among authors: tanabe k. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:83-6. Gan To Kagaku Ryoho. 2006. PMID: 16897978 Clinical Trial. Japanese.

2

Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.

Yoshida K, Tanabe K, Fujii D, Oue N, Yasui W, Toge T. Yoshida K, et al. Among authors: tanabe k. Anticancer Res. 2003 Jan-Feb;23(1A):267-73. Anticancer Res. 2003. PMID: 12680223

3

Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study.

Yoshida K, Tanabe K, Ueno H, Ohta K, Hihara J, Toge T, Nishiyama M. Yoshida K, et al. Among authors: tanabe k. Gastric Cancer. 2003;6 Suppl 1:82-9. doi: 10.1007/s10120-003-0224-9. Gastric Cancer. 2003. PMID: 12775025 Clinical Trial.

4

[Weekly docetaxel therapy is useful for gastric carcinoma as a second-line chemotherapy].

Yoshida K, Ohta K, Hihara J, Tanabe K, Minami K, Yamaguchi Y, Toge T. Yoshida K, et al. Among authors: tanabe k. Gan To Kagaku Ryoho. 2003 Nov;30(12):1927-32. Gan To Kagaku Ryoho. 2003. PMID: 14650961 Japanese.

5

Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.

Kim R, Osaki A, Tanabe K, Toge T. Kim R, et al. Among authors: tanabe k. Oncol Rep. 2004 Jun;11(6):1265-72. Oncol Rep. 2004. PMID: 15138565

6

The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.

Fujii D, Yoshida K, Tanabe K, Hihara J, Toge T. Fujii D, et al. Among authors: tanabe k. Anticancer Res. 2004 May-Jun;24(3a):1409-16. Anticancer Res. 2004. PMID: 15274302 Free article.

7

Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma.

Kim R, Emi M, Tanabe K, Toge T. Kim R, et al. Among authors: tanabe k. Cancer. 2004 Nov 15;101(10):2177-86. doi: 10.1002/cncr.20636. Cancer. 2004. PMID: 15476281 Free article.

8

Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.

Kim R, Emi M, Tanabe K, Toge T. Kim R, et al. Among authors: tanabe k. Cancer. 2004 Dec 1;101(11):2491-502. doi: 10.1002/cncr.20696. Cancer. 2004. PMID: 15503311 Free article. Review.

9

[Weekly paclitaxel therapy is useful for gastric carcinoma as second-line chemotherapy].

Mizuiri H, Yoshida K, Shimizu K, Tanabe K, Taomoto J, Suzuki T, Wada Y, Hihara J. Mizuiri H, et al. Among authors: tanabe k. Gan To Kagaku Ryoho. 2004 Nov;31(12):2043-6. Gan To Kagaku Ryoho. 2004. PMID: 15570937 Japanese.

10

Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.

Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T. Kim R, et al. Among authors: tanabe k. Cancer. 2005 May 1;103(9):1800-9. doi: 10.1002/cncr.20973. Cancer. 2005. PMID: 15786421 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,084 results

Search Page

Filters